Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 6, 1999, Pages 649-652

  Buemi, Michele ^a   Allegra, Alessandro ^a   Corica, Francesco ^a   Rucllo, Antonella ^a   Aloisi, Camela ^a   Pettinato, Giuseppina ^a   Giacobbe, MariaStella ^a   Romeo, Adolfo ^a   Frisina, Nicola ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; LISINOPRIL;

ADULT; APOPTOSIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; PROTO ONCOGENE; RISK FACTOR;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; APOPTOSIS; FEMALE; GENES, BCL-2; GLOMERULONEPHRITIS, IGA; HUMANS; LISINOPRIL; MALE; MIDDLE AGED; PROTEINURIA; TREATMENT OUTCOME;

EID: 0032977605     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)90086-3     Document Type: Article

References (18)

1. 1. De Zeeuw D, Heeg JE, De Jong PE. The antiproteinuric effect of angiotensin-converting enzyme inhibitors in human renal disease. In: Andreucci VE, Fine LG, editors. International Yearbook of Nephrotogy 1992. London: Springer-Verlag; 1991. p. 95-112.
2. 2. Remuzzi A, Perticucci E, Ruggeneti P, Mosconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991;39:1267-73.
3. 3. D'Amico G, Colasanti G, di Belgioioso G, Fellin G, Ragni A, Egidi F, et al. Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol 1987;7:355-8.
4. 4. Kyoichi T, Sanki K, Yutaka T, Satoshi H, Isao S, Yasuhiko T. Detection of apoptotic cells in glomeruli of patients with IgA nephropathy. Nephron 1998;79:21-7.
5. 5. Mene P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989;69:1374-424.
6. 6. Yoshioka K, Maki S. Human IgA nephritis: immunocytochemical evidence of a chronic inflammatory proliferative disorder. Histol Histopathol 1995;10:203-12.
7. 7. Kroemer G. The proto-oncogene bcl-2 and its role in regulating apoptosis [published erratum appears in Nat Med 1997;3:934]. Nat Med 1997;3:614-20.
8. 8. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94:2105-16.
9. 9. Pirani CL, Solinas-Madrigal L. Evaluation of percutaneous renal biopsy. Pathol A 1969;3:249-96.
10. 10. Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transpl 1994;9:255-69.
11. 11. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995;47:114-21.
12. 12. Ruiz-Gines JA, Perez-Caballero C, O'Valle F, Rodriguez-Puyol M, Rodriguez-Puyol D. Captopril inhibits pp60(c-src) tyrosine phosphorylation in cultured human mesangial cells. Eur J Pharmacol 1997;336:251-6.
13. 13. Ortiz A, Karp SL, Danoff TM, Neilson EG. Expression of survival promoting bcl-2 oncogene by renal cells and whale kidney [abstract]. J Am Soc Nephrol 1993;4:742.
14. 14. Harrison DJ. Cell death in the diseased glomerulus. Histopathology 1988;12:679-83.
15. 15. Savill J. Apoptosis and the kidney. J Am Soc Nephrol 1994;5:12-21.
16. 16. Diez J, Reed JC, Krajewski S, Panizo A, Hernandez M, Pardo J. ACE inhibition modulates the apoptosis-regulatory proteins bcl-2 and bax in vascular spontaneously hypertensive rats (SHR). Am J Hypertens 1996;9:3-4A.
17. 17. Steinmann-Niggli K, Lukes M, Marti HP. Rat mesangial cells and matrix metalloproteinase inhibitor: inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation. J Am Soc Nephrol 1997;8:395-405.
18. 18. Buemi M, Allegra A, Marino D, Marino MT, Medici MA, De Pasquale G, et al. Does captopril have a direct proapoptotic effect? Nephron 1999;81:99-101.